Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEEFB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,133
Award facts
- Contract value 100% obligated
- $24,132.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $24,132.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 7, 2026, with an ultimate completion date of January 8, 2026, represents a routine procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform all work at its Park Ridge, Illinois location.
This delivery order falls under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors for supplying pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award IDC under this program with a ceiling value of $499,999,999 and completion date of December 31, 2036, positioning the company as a critical supplier of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and specialty pharmaceutical products to support military healthcare operations. The contractor's established performance across numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEEFB?
SPE2DU26FEEFB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DU26FEEFB worth?
The government has obligated $24,133 on SPE2DU26FEEFB.
Is contract SPE2DU26FEEFB an order under another contract?
Yes. SPE2DU26FEEFB is a delivery order under SPE2DU25D9439, an indefinite delivery contract.
Was contract SPE2DU26FEEFB competed?
The extent of competition for SPE2DU26FEEFB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award